FDA Investigator Parul Patel Sullivan
Parul Patel Sullivan has inspections in 1 countries as of 26 Apr 2023. Parul Patel Sullivan has collaborated with a combined 701 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
2
Last Inspection Date:
26 Apr 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America
Co-Investigator(s):
Anthony F Lorenzo,
Brian R Yaun,
Brooke K Higgins,
Brooke K Seeman,
Burnell M Henry,
Candice C Mandera,
Candice J Cortes,
CDR Ileana Barreto Pettit,
Christian D Lynch (CDL),
David A Oluwo,
Douglas A Campbell,
Dr. Gang Wang, PhD,
Emest F Bizjak,
Gerald B Seaborn, Jr,
Jacqueline Mdiaz Albertini,
Jessica L Pressley,
Jonathan W Chapman,
Jose R Hernandez,
Justin A Boyd,
Kenneth Nieves,
Lawrence J Stringer,
LCDR Debra Emerson,
Marcus A Ray,
Melissa J Garcia,
Mihaly S Ligmond,
Nawab A Siddiqui,
Nebil A Oumer,
Parul M Patel,
Qin Xu,
Rachel C Harrington,
Robert J Maffei,
Robin Levis, PhD,
Steven J Thurber,
Steven P Donald,
Susan M Jackson,
Swati Verma,
Temar Q Williams,
Thai D Truong,
Thomas R Withers
Parul Patel Sullivan's Documents
Publish Date | Document Type | Title |
---|---|---|
March, 2000 | FDA 483 | Merck Sharp & Dohme LLC - Form 483, 2000-03-17 |
March, 2000 | EIR | Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. - EIR, 2000-03-17 |
March, 2000 | FDA 483 Response | Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. - Form 483R, 2000-03-31 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more